Literature DB >> 6769939

Grades of subclinical hypothyroidism in asymptomatic autoimmune thyroiditis revealed by the thyrotropin-releasing hormone test.

P A Bastenie, M Bonnyns, L Vanhaelst.   

Abstract

Serum levels of T4 T3, and TSH and peak TSH after TRH administration were determined in 60 female subjects affected with asymptomatic autoimmune thyroiditis (AAT), in 27 normal subjects, and in 8 myxoedematous patients used as controls. The AAT subjects were divided into 3 groups on the basis of their basal and peak TSH values. In the first group (grade I AAT), these parameters were similar to those of the normal controls; in the second (grade II AAT), basal TSH remained normal but peak TSH was significantly increased; and in the third (grade III AAT), both parameters were significantly increased. Serum T4 levels decreased progressively from group 1 to group 3, but all T4 values were within the normal range. T3 levels were similar in all groups. Peak and basal TSH values were highly correlated, except in grade II AAT. There seems to exist a graded process of subclinical hypothyroidism in AAT; a progressive pituitary TSH reserve is modulated by a progressive decrease in T4 levels still within the normal range.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6769939     DOI: 10.1210/jcem-51-1-163

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  10 in total

Review 1.  Thyroxine replacement treatment and osteoporosis.

Authors:  J A Franklyn; M C Sheppard
Journal:  BMJ       Date:  1990-03-17

2.  Thyroid hormones and cognitive functioning in healthy, euthyroid women: a correlational study.

Authors:  Miglena Grigorova; Barbara B Sherwin
Journal:  Horm Behav       Date:  2012-02-20       Impact factor: 3.587

Review 3.  Cardiovascular Risk in Patients with Subclinical Hypothyroidism.

Authors:  L H Duntas; Luca Chiovato
Journal:  Eur Endocrinol       Date:  2014-08-28

4.  Role of smoking in goiter morphology and thyrotropin response to TRH in untreated goitrous women.

Authors:  S Lio; G Napolitano; G Marinuzzi; F Monaco
Journal:  J Endocrinol Invest       Date:  1989-02       Impact factor: 4.256

5.  Thyroid volume in type 1 diabetes patients without overt thyroid disease.

Authors:  G Bianchi; P Montanari; A Fabbri; A Gamberini; M Zoli; G Marchesini
Journal:  Acta Diabetol       Date:  1995-03       Impact factor: 4.280

6.  Thyroid hormone metabolism in thyroid disease as reflected by the ratio of serum triiodothyronine to thyroxine.

Authors:  E M Erfurth; P Hedner
Journal:  J Endocrinol Invest       Date:  1986-10       Impact factor: 4.256

Review 7.  The clinician and the thyroid.

Authors:  H J Biersack; A Hotze
Journal:  Eur J Nucl Med       Date:  1991

8.  Circulating thyroid and gastric parietal cell autoantibodies in patients with multiple sclerosis.

Authors:  C Ioppoli; G Meucci; S Mariotti; E Martino; A Lippi; L Gironelli; A Pinchera; A Muratorio
Journal:  Ital J Neurol Sci       Date:  1990-02

9.  Comparison of a new ultrafiltration method for serum free T4 and free T3 with two RIA kits in eight groups of patients.

Authors:  Y S Wang; A E Pekary; M L England; J M Hershman
Journal:  J Endocrinol Invest       Date:  1985-12       Impact factor: 4.256

10.  Thyroid involvement in chronic inflammatory rheumatological disorders.

Authors:  G Bianchi; G Marchesini; M Zoli; M C Falasconi; T Iervese; F Vecchi; D Magalotti; S Ferri
Journal:  Clin Rheumatol       Date:  1993-12       Impact factor: 2.980

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.